Harpoon Therapeutics, Inc.

/Harpoon Therapeutics, Inc.

We are a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases

Symbol

Final Price
$14.00

Final Shares
5,400,000

Effective Date
February 8, 2019

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange